Manuscripts
Showing 1591 manuscripts.
Population Pharmacokinetics of Lopinavir/Ritonavir: Changes Across Formulations and Human Development From Infancy Through Adulthood
Citation
Jincheng Yang, Mina Nikanjam, Brookie M Best, Jorge Pinto, Ellen G Chadwick, Eric S Daar, Peter L Havens, Natella Rakhmanina, Edmund V Capparelli. Population Pharmacokinetics of Lopinavir/Ritonavir: Changes Across Formulations and Human Development From Infancy Through Adulthood. Journal of Clinical Pharmacology. 2018 Dec 01; 58(12):1604-1617. PMID: 30252146; PMCID: PMC6604805.Year
2018
Journal
Journal of Clinical Pharmacology
Study
P1030, P1038, P1083
Persistence of memory B-cell and T-cell responses to the quadrivalent HPV vaccine in HIV-infected children.
Citation
Weinberg A, Huang S, Moscicki AB, Saah A, Levin MJ, IMPAACT P1085 Protocol Team. Persistence of memory B-cell and T-cell responses to the quadrivalent HPV vaccine in HIV-infected children. AIDS. 2018 Apr 24; 32(7):851-860. PMID: 29424778; PMCID: PMC5869173.Year
2018
Journal
AIDS
Study
P1085
Quantification of variation and the impact of biomass in targeted 16S rRNA gene sequencing studies.
Citation
JM Bender, F Li, H Adisetivo, D Lee, S Zabih, L Hung, TA Wiklinson, PS Pannaraj, RC She, JD Bard, NH Tobin, GM Aldrovandi. Quantification of variation and the impact of biomass in targeted 16S rRNA gene sequencing studies. Microbiome. 2018 Sep 10; 6(1):155. PMID: 30201048; PMCID: PMC6131952.Year
2018
Journal
Microbiome
Meta-analysis of effects of exclusive breastfeeding on infant gut microbiota across populations.
Citation
NT Ho, F Li, KA Lee-Sarwar, HM Tun, BP Brown, PS Pannaraj, JM Bender, MB Azad, AL Thompson, ST Weiss, MA Azcarate-Peril, AA Litonjua, AL Kozyrskyi, HB Jaspan, GM Aldrovandi, L Kuhn. Meta-analysis of effects of exclusive breastfeeding on infant gut microbiota across populations. Nature Communications. 2018 Oct 09; 9(1):4169. PMID: 30301893; PMCID: PMC6177445.Year
2018
Journal
Nature Communications
Safety and efficacy at 240 weeks of different raltegravir formulations in children with HIV-1: a phase 1/2 open label, non-randomised, multicentre trial.
Citation
S Nachman, C Alvero, H Teppler, B Homony, AJ Rodgers, BL Graham, T Fenton, LM Frenkel, RS Browning, R Hazra, AA Wiznia, IMPAACT 1066 Study Team. Safety and efficacy at 240 weeks of different raltegravir formulations in children with HIV-1: a phase 1/2 open label, non-randomised, multicentre trial. Lancet HIV. 2018 Dec 04; 5(12):e715-e722. PMID: 30527329; PMCID: PMC6537590.Year
2018
Journal
Lancet HIV
Study
P1066
Maternal health outcomes among HIV-infected breastfeeding women with high CD4 counts: results of a treatment strategy trial
Citation
Risa M Hoffman, Konstantia Nadia Angelidou, Sean S Brummel, Friday Saidi, Avy Violari, Dingase Dula, Vidya Mave, Lee Fairlie, Gerhard Theron, Moreen Kamateeka, Tsungai Chipato, Benjamin H Chi, Lynda Stranix-Chibanda, Teacler Nematadzira, Dhayendre Moodley, Debika Bhattacharya, Amita Gupta, Anne Coletti, James A McIntyre, Karin L Kingman, Nahida Chakhtoura, David E Shapiro, Mary Glenn Fowler, Judith S Currier, IMPAACT PROMISE 1077BF/FF Team. Maternal health outcomes among HIV-infected breastfeeding women with high CD4 counts: results of a treatment strategy trial. HIV Clinical Trials. 2018 Dec 01; 19(6):209-224. PMID: 30890061; PMCID: PMC6428202.Year
2018
Journal
HIV Clinical Trials
Study
1077BF, 1077FF
Defining Study Outcomes That Better Reflect Individual Response to Treatment
Citation
Konstantia Angelidou, Paul Palumbo, Jane Lindsey, Avy Violary, Moderndran Archary, Linda Barlow, Brian Claggett, Michael Hughes, Lee-Jen Wei, IMPAACT P1060 Study Team. Defining Study Outcomes That Better Reflect Individual Response to Treatment. Pediatric Infectious Disease Journal. 2018 Mar 06; 37(3):258-262. PMID: 29189677; PMCID: PMC5807218.Year
2018
Journal
Pediatric Infectious Disease Journal
Study
P1060
A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women
Citation
Stein Schalkwijk, Rob Ter Heine, Angela C Colbers, Alwin D R Huitema, Paolo Denti, Kelly E Dooley, Edmund Capparelli, Brookie M Best, Tim R Cressey, Rick Greupink, Frans G M Russel, Mark Mirochnick, David M Burger. A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women. Clinical Pharmacokinetics. 2018 Nov 01; 57(11):1421-1433. PMID: 29520730; PMCID: PMC6182466.Year
2018
Journal
Clinical Pharmacokinetics
Study
P1026S
H1N1 influenza vaccination in HIV-infected women on effective antiretroviral treatment does not appear to impact HIV-1 DNA genotypes or concentration
Citation
Thor A. Wagner, Hannah C. Huang, Christen E. Salyer, Kelly M. Richardson, Adriana Weinberg, Sharon Nachman, Lisa M. Frenkel. H1N1 influenza vaccination in HIV-infected women on effective antiretroviral treatment does not appear to impact HIV-1 DNA genotypes or concentration. Journal of Acquired Immune Deficiency Syndromes. 2017 Feb 16; 14(1):7. PMID: 28193244; PMCID: PMC5307755.Year
2017
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
P1086
Sexually Transmitted Infections in Youth With Controlled and Uncontrolled Human Immunodeficiency Virus Infection
Citation
Andres F. Camacho-Gonzalez , Miriam C. Chernoff, Paige L. Williams, Ann Chahroudi , James M. Oleske , Shirley Traite , Rana Chakraborty, Murli U. Purswani , Mark J. Abzug , IMPAACT P1074 Study Team. Sexually Transmitted Infections in Youth With Controlled and Uncontrolled Human Immunodeficiency Virus Infection. Journal of Pediatric Infectious Disease Society. 2017 Sep 01; 6(3):e22-e29. PMID: 27440505; PMCID: PMC5907850.Year
2017
Journal
Journal of Pediatric Infectious Disease Society
Study
P1074